biOasis Technologies Inc.: 2012-2013 Board of Directors Election, Officers Appointment and Option Grant
(firmenpresse) - VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 08/28/12 -- biOasis Technologies Inc. (TSX VENTURE: BTI) announces its board of directors elected by the shareholders at its Annual General Meeting held today:
The Board also appointed the following officers of the Company:
The Company also announces that is has granted as of close of business today 328,000 incentive stock options to officers and directors of the Company exercisable at $1.28 per share expiring on August 28, 2017. The options shall vest according to company's stock option plan.
ABOUT BIOASIS:
biOasis Technologies Inc. is a biopharmaceutical company engaged in the development and commercialization of products for the diagnosis and treatment of neurological diseases and disorders. Its products and technologies are intended for use within the healthcare and life science research markets. The Company is currently developing Cognitest™, a blood test for the diagnosis of Alzheimer's disease. biOasis is also developing Transcend, a proprietary molecular carrier intended to transport drugs across the Blood-Brain Barrier for treatment of a wide range of neurological, oncological and infectious disease applications.
On Behalf of the Board of Directors
Rob Hutchison, Chairman & CEO
"Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release."
Contacts:
biOasis Technologies Inc.
Rob Hutchison
Chairman & CEO
(778) 383.3280
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 28.08.2012 - 23:36 Uhr
Sprache: Deutsch
News-ID 178449
Anzahl Zeichen: 0
contact information:
Town:
VANCOUVER, BRITISH COLUMBIA
Kategorie:
Medical Devices
Diese Pressemitteilung wurde bisher 315 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"biOasis Technologies Inc.: 2012-2013 Board of Directors Election, Officers Appointment and Option Grant"
steht unter der journalistisch-redaktionellen Verantwortung von
biOasis Technologies Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
